are all brands of zantac recall?
148558
Dr. Reddy's Laboratories Ltd is voluntary recalling all prescription and over-the-counter (OTC) ranitidine tablets and capsules manufactured by the company. The OTC medicines may be labeled by retailers such as Walgreens, Walmart, CVS, Target, and Kroger.
589607
Ranitidine (also known by its brand name, Zantac, which is sold by the drug company Sanofi) is available both over the counter (OTC) and by prescription. It belongs to the class of drugs known as H2 (or histamine-2) blockers.
623299
Update [11/12/2019] FDA is alerting patients and health care professionals to two voluntary recalls of ranitidine. Amneal voluntarily recalled prescription ranitidine hydrochloride tablets (150mg and 300mg) and ranitidine syrup (15mg/mL) manufactured by Amneal Pharmaceuticals LLC.
1288925
Blood pressure drug recall: Teva pulls losartan tablets tainted with possible carcinogen. Teva Pharmaceuticals this week expanded its recall of losartan potassium tablets after detecting a possible human carcinogen in the blood pressure medication.
70170
Losartan. In December, the FDA announced a voluntary recall of losartan potassium tablets USP. An addition eight lots of Torrent Pharmaceuticals' losartan tablets were added to a previous recall in January. See which products were affected by the recall.
917492
Benicar Recall To date, the FDA nor Daiichi Sankyo, the maker of low blood pressure treatment medication, has yet to recall Benicar due to its link with causing sprue-like enteropathy.
572984
Update [12/18/2019] FDA is alerting patients and health care professionals to Glenmark Pharmaceutical Inc.'s voluntary recall of prescription ranitidine tablets (150 mg and 300 mg). The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA).
611118
Irbesartan. In July, the FDA announced a voluntary recall of irbesartan tablets. See which products were affected by the recall. In January 2019, Prinston Pharmaceutical Inc., doing business as Solco Healthcare LLC, voluntarily recalled eight llots of irbersartan-based drugs.
545381
As a precautionary measure, Perrigo Company plc announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes). ... On October 8, 2019, Perrigo halted shipments of the product based upon preliminary results.
413149
Update [8/20/2018] FDA is alerting health care professionals and patients that Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of valsartan/amlodipine/hydrochlorothiazide (HCTZ) tablets. Not all Torrent valsartan products distributed in the U.S. are being recalled.
982818
Officials with Alembic Pharmaceuticals, Inc. have issued a statement to patients, doctors, and pharmacists that Alembic's Valsartan containing products (Valsartan, Valsartan & Hydrochlorothiazide, Amlodipine & Valsartan) are not subject to the recent FDA recall.
459882
Reddy's Laboratories, the manufacturer of Kroger, Walgreen and CVS branded ranitidine products has issued a voluntary recall. Products dated for expiration between September 2019 and June 2021 are affected. These medications are over the counter and are used to treat heartburn.
1042022
Other companies that have also recalled several lots of their products include Macleods Pharmaceuticals, Camber Pharmaceuticals, Legacy Pharmaceuticals Packaging, Teva Pharmaceuticals and Vivimed Life Sciences voluntarily recalled losartan potassium tablets because of trace amounts of impurities found in an active ...
33746
Officials at the Food and Drug Administration (FDA) have ordered all ranitidine medications, sold under the brand name Zantac, taken off store shelves immediately. The order is tied to concerns that the medication may contain a cancer-causing chemical that's also been detected in certain blood pressure medications.
804311
Update [8/20/2018] FDA is alerting health care professionals and patients that Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of valsartan/amlodipine/hydrochlorothiazide (HCTZ) tablets.
478373
The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day or 0.32 parts per million for ranitidine).
126632
Clinicians should be aware that not all lots of valsartan, irbesartan and losartan products are being recalled, and other ARBs, including candesartan, eprosartan, olmesartan and telmisartan, have not been recalled.